Key View

• We at Fitch Solutions believe that the UK and the European Union (EU) will reach a new agreement on goods trade in 2020, though this will fall short of the UK’s current access to the EU’s Single Market.
• This will lead to some non-tariff barriers to UK-EU trade from January 1, 2021, such as administrative costs of complying with rules

Key View

• This amendment to Mallinckrodt's business separation plans highlights improving fortunes for its Specialty Generics segment.
• Increasing revenues from sales of Amitiza will help to bolster the Specialty Brands segment, which remains the larger of the two segments, but which has seen revenues falter in recent quarters.
• The Specialty

Alzheimer's Research UK is to fund a clinical trial at King's College London investigating a cannabis-based treatment for people living with dementia. The charity is committing nearly GBP300,000 (USD398,883) for a Phase II trial of GW Pharmaceuticals' Sativex (nabiximols), a cannabis-based medicine licensed in the UK for the treatment of muscle

The UK parliament voted against Prime Minister Theresa May’s ‘Brexit Deal’ by 432 votes to 202, marking the largest margin since 1924. Following the crushing defeat, opposition Labour leader Jeremy Corbyn tabled a vote of no confidence, which could trigger an early election. Our team in Europe will follow up with more details, but at first glance

Key View

• The defeat of UK Prime Minister Theresa May's Brexit withdrawal agreement, by a record margin, means there are now three Brexit options left on the table: no deal Brexit, a second referendum, and a soft Brexit.
• The government is likely to win the vote of no confidence to be held on January 16, but this offers little respite, with the